Cost of Care for Juvenile Idiopathic Arthritis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01469897

Enrollment

165

Registered

2011-11-10

Start date

2012-01-31

Completion date

2017-03-31

Last updated

2018-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile Idiopathic Arthritis

Keywords

JIA, Juvenile Idiopathic Arthritis, Cost of Care, Quality of Life, QOL

Brief summary

This project seeks to collect data on healthcare utilization and expenditure rates in Juvenile Idiopathic Arthritis (JIA) patients from across the US, correlate these costs with disease activity and outcome measures and determine methods by which to reduce the economic impact while improving outcomes.

Detailed description

SPECIFIC AIMS AND OBJECTIVES The specific aims of this registry protocol are: * To create and maintain a secure online database of patients with JIA * To collect data elements related to cost of care in patients with JIA * Compare standard outcome and disease activity measures to health care expenditures in JIA * To determine methods by which to reduce costs while improving outcomes and quality of care The study plans to enroll 300 or more subjects from 3 medical centers in the US over a 24 month period. Subjects in the study are patients with Juvenile Idiopathic Arthritis. Enrollment into the protocol will include key demographic and clinical data including, medication exposures, disease severity, and function including disease-specific data elements; and estimates of health care service utilization and health care expenditures. Data will be collected once per subject within the context of a standard of care visit.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Subject has been diagnosed with JIA by a pediatric rheumatologist according to published criteria. * Person providing consent must be able to read English. * Subject (and/or parent/legal guardian) is able to provide informed consent and willing to comply with study procedures.

Exclusion criteria

* Subject/ legal guardian is unwilling to provide consent, cannot read English, or does not meet published criteria for JIA. * Coexisting rheumatologic disorder * Diagnosis of fibromyalgia * Participation in a drug trial in the past 6 months.

Design outcomes

Primary

Measure	Time frame	Description
Direct and indirect costs	6 months prior to enrollment	Patient's history will be reviewed for the prior 6 months to enrollment for expenses incurred related to JIA and it's treatment. This will be done through chart review and questionnaires completed by the patient/parent.

Secondary

Measure	Time frame	Description
Health related quality of life questionnaires	Day 1	Self reported questionnaires will be completed by parent.

Countries

United States

Outcome results